Clinical Study

Association between Admission Hyperglycemia and Culprit Lesion Characteristics in Nondiabetic Patients with Acute Myocardial Infarction: An Intravascular Optical Coherence Tomography Study

Table 2

Culprit lesion characteristics of the study population by optical coherence tomography.

Non-DM patients by A/C tertilesDM
versus DM
versus DM versus DM versus DM
<1.08
1.08-1.22
>1.22

Plaque morphology0.0020.1300.0250.0160.222
 Plaque rupture86 (47.3)23 (38.3)23 (37.1)40 (66.7)54 (56.8)
 Plaque erosion96 (52.7)37 (61.7)39 (62.9)20 (33.3)41 (43.2)
Plaque type0.0010.012<0.0010.0070.669
 Lipid-rich plaque96 (52.7)24 (40.0)29 (46.8)43 (71.7)65 (68.4)
 Fibrous plaque86 (47.3)36 (60.0)33 (53.2)17 (28.3)30 (31.6)
TCFA36 (19.8)5 (8.3)13 (21.0)18 (30.0)0.00333 (34.7)0.006<0.0010.0220.406
Macrophage infiltration94 (51.6)26 (43.3)34 (54.8)34 (56.7)0.14557 (60.0)0.1850.0490.6200.739
Microvessels32 (17.6)13 (21.7)7 (11.3)12 (20.0)0.81117 (17.9)0.9480.6770.3650.833
Cholesterol crystal10 (5.5)3 (5.0)4 (6.5)3 (5.0)1.00012 (12.6)0.0370.1180.2110.118
Calcification84 (46.2)29 (48.3)33 (53.2)22 (36.7)0.20159 (62.1)0.0120.0920.2700.002
Thrombus176 (96.7)58 (96.7)59 (95.2)59 (98.3)0.61094 (98.9)0.2590.5600.3010.599
FCT (μm)100.0 (70.0, 130.0)110.0 (80.0, 140.0)110.0 (70.0, 140.0)90.0 (60.0, 115.0)0.01090.0 (60.0, 120.0)0.0670.0130.0520.840
Maximal lipid arc (°)360 (242, 360)322.3 (241.5, 360.0)339.5 (235.0, 360.0)360.0 (262.0, 360.0)0.173360.0 (242.0, 360.0)0.2950.1840.1690.752
MLA (mm2)1.73 (1.36, 2.23)1.55 (1.28, 2.39)1.74 (1.44, 2.17)1.75 (1.35, 2.32)0.6541.72 (1.50, 2.14)0.3810.3880.4140.744

Data shown are number (%) or median (25th percentile, 75th percentile). DM: diabetes mellitus; FCT: fibrous cap thickness; MLA: minimal lumen area; non-DM: patients without diabetes mellitus; TCFA: thin-cap fibroatheroma.